Catheter-based transarterial therapies for hepatocellular cancer

Cleve Clin J Med. 2015 Dec;82(12):828-34. doi: 10.3949/ccjm.82a.14085.

Abstract

As the prevalence of liver cancer increases, so does the demand for nonsurgical, minimally invasive alternatives to surgery, since many patients have tumors that cannot be surgically resected. Catheter-based hepatic arterial procedures may be an option in patients with primary and metastatic liver cancer. The authors describe four catheter-based hepatic arterial procedures and outline the management of potential complications during the immediate postprocedural period.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Carcinoma, Hepatocellular / blood supply
  • Carcinoma, Hepatocellular / therapy*
  • Chemoembolization, Therapeutic*
  • Cisplatin / administration & dosage
  • Doxorubicin / administration & dosage
  • Embolization, Therapeutic*
  • Humans
  • Liver Neoplasms / blood supply
  • Liver Neoplasms / therapy*
  • Mitomycin / administration & dosage
  • Postoperative Care
  • Postoperative Complications
  • Radiotherapy*
  • Yttrium Radioisotopes / therapeutic use*

Substances

  • Antineoplastic Agents
  • Yttrium Radioisotopes
  • Mitomycin
  • Doxorubicin
  • Cisplatin